Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues

World Journal of Biological Psychiatry

Volumn 19, Issue 8, 2018, Pages 610-618

  Milanesi, Elena ^a   Zanardini, Roberta ^a   Rosso, Gianluca ^b   Maina, Giuseppe ^b   Barbon, Alessandro ^c   Mora, Cristina ^c   Minelli, Alessandra ^c   Gennarelli, Massimo ^a,c   Bocchio Chiavetto, Luisella ^a,d  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d ECAMPUS UNIVERSITY   (Italy)

Author keywords

bipolar disorder; fibroblasts; IGFBP2; major depressive disorder; serum

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; MESSENGER RNA; NEUROLEPTIC AGENT; SOMATOMEDIN BINDING PROTEIN 2; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; MONOTHERAPY; MRNA EXPRESSION LEVEL; POST HOC ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION LEVEL; PSYCHOPHARMACOTHERAPY; SEX RATIO; SKIN FIBROBLAST; BLOOD; DOWN REGULATION; GENE EXPRESSION; GENETICS;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 85012873212     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622975.2017.1282172     Document Type: Article

References (39)

1. Aberg ND, Brywe KG, Isgaard J., 2006. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J [Internet]. 6:53–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16432628
2. Aizenman Y, de Vellis J., 1987. Brain neurons develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation. Brain Res [Internet]. 406:32–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3105814
3. Akin D, Manier DH, Sanders-Bush E, Shelton RC., 2004. Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology [Internet]. 29:2081–2087. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15187984
4. Bezchlibnyk YB, Wang J-F, Shao L, Young LT., 2006. Insulin-like growth factor binding protein-2 expression is decreased by lithium. Neuroreport [Internet]. 17:897–901. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16738484
5. Bezchlibnyk YB, Xu L, Wang J-F, Young LT., 2007. Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment. Brain Res [Internet]. 1147:213–217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17395163
6. Blum WF, Horn N, Kratzsch J, Jørgensen JO, Juul A, Teale D, Mohnike K, Ranke MB. 1993. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul [Internet]. 3:100–104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7683512
7. Cattane N, Minelli A, Milanesi E, Maj C, Bignotti S, Bortolomasi M, Bocchio Chiavetto L, Gennarelli M. 2015. Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood. PLoS One [Internet]. 10:e0116686. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25658856
8. Chadelat K, Boule M, Corroyer S, Fauroux B, Delaisi B, Tournier G, Clement A. 1998. Expression of insulin-like growth factors and their binding proteins by bronchoalveolar cells from children with and without interstitial lung disease. Eur Respir J [Internet]. 11:1329–1336. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9657575
9. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, et al. 2011. A critical role for IGF-II in memory consolidation and enhancement. Nature [Internet]. 469:491–497. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3908455&tool=pmcentrez&rendertype=abstract
10. Chesik D, De Keyser J, Wilczak N., 2007. Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis. Cytokine Growth Factor Rev [Internet]. 18:267–278. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17485236
11. Collett-Solberg PF, Cohen P., 1996. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am [Internet]. 25:591–614. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8879988
12. Firth SM, Baxter RC., 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev [Internet]. 23:824–854. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12466191
13. Garbett KA, Vereczkei A, Kálmán S, Wang L, Korade Ž, Shelton RC, Mirnics K. 2015. Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors. Transl Psychiatry [Internet]. 5:e523. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25756806
14. Hasegawa Y, Hasegawa T, Takada M, Tsuchiya Y., 1996. Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents. Eur J Endocrinol [Internet]. 134:184–189. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8630517
15. Haugaard SB, Andersen O, Hansen BR, Orskov H, Andersen UB, Madsbad S, Iversen J, Flyvbjerg A. 2004. Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients. Metabolism [Internet]. 53:1565–1573. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15562401
16. Hayashi-Takagi A, Vawter MP, Iwamoto K., 2014. Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biol Psychiatry [Internet]. 75:920–928. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24286759
17. Hirschfeld RMA., 2013. The unrecognized side of bipolar disorder. Am J Psychiatry [Internet]. 170:815–817. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23903327
18. Kálmán S, Garbett KA, Janka Z, Mirnics K., 2016. Human dermal fibroblasts in psychiatry research. Neuroscience [Internet]. 320:105–121. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26855193
19. Kim Y-K, Na K-S, Hwang J-A, Yoon H-K, Lee H-J, Hahn S-W, Lee BH, Jung HY. 2013. High insulin-like growth factor-1 in patients with bipolar I disorder: a trait marker? J Affect Disord [Internet]. 151:738–743. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24012102
20. Kumarasinghe N, Tooney PA, Schall U., 2012. Finding the needle in the haystack: a review of microarray gene expression research into schizophrenia. Aust NZ J Psychiatry [Internet]. 46:598–610. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22441207
21. Lamers F, Bot M, Jansen R, Chan MK, Cooper JD, Bahn S, Penninx BW. 2016. Serum proteomic profiles of depressive subtypes. Transl Psychiatry [Internet]. 6:e851. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=27404283
22. Leventhal PS, Russel JW, Feldman EL., 1999. IGFs and the nervous system. In: The IGF system. Totowa (NJ): Humana Press; p. 425–455. Available from: http://link.springer.com/10.1007/978-1-59259-712-3_19
23. Liu X, Zhang T, He S, Hong B, Chen Z, Peng D, Wen H, Lin Z, Fang Y, Jiang K. 2014. Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder. Psychiatry Res [Internet]. 218:54–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24793757
24. Machado-Vieira R, Manji HK, Zarate CA., 2009. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord [Internet]. 11(Suppl 2):92–109. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19538689
25. Machado-Vieira R, Soeiro-De-Souza MG, Richards EM, Teixeira AL, Zarate CA., 2014. Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J Biol Psychiatry [Internet]. 15:84–95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23998912
26. Milanesi E, Hadar A, Maffioletti E, Werner H, Shomron N, Gennarelli M, Schulze TG, Costa M, Del Zompo M, Squassina A, et al. 2015. Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients. J Mol Neurosci [Internet]. 56:681–687. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25740013
27. Palomino A, González-Pinto A, Martinez-Cengotitabengoa M, Ruiz de Azua S, Alberich S, Mosquera F, Matute C. 2013. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients. Prog Neuropsychopharmacol Biol Psychiatry [Internet]. 44:29–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23337034
28. Pereira AC, McQuillin A, Puri V, Anjorin A, Bass N, Kandaswamy R, Lawrence J, Curtis D, Sklar P, Purcell SM. 2011. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet [Internet]. 156:177–187. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21302346
29. Pfaffl MW., 2001. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res [Internet]. 29:e45. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55695/
30. Rege S, Hodgkinson SJ., 2013. Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application. Aust NZ J Psychiatry [Internet]. 47:1136–1151. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23908311
31. Reindl KM, Sheridan MA., 2012. Peripheral regulation of the growth hormone-insulin-like growth factor system in fish and other vertebrates. Comp Biochem Physiol A Mol Integr Physiol [Internet]. 163:231–245. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22909791
32. Scola G, Andreazza AC., 2015. The role of neurotrophins in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry [Internet]. 56:122–128. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25193130
33. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry [Internet]. 59(Suppl 2):22–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9881538
34. Soto L, Martín AI, Millán S, Vara E, López-Calderón A., 1998. Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. J Endocrinol [Internet]. 159:239–246. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9795364
35. Squassina A, Costa M, Congiu D, Manchia M, Angius A, Deiana V, Ardau R, Chillotti C, Severino G, Calza S, et al. 2013. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol. Res [Internet]. 73:1–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23619527
36. Suh H-S, Lo Y, Choi N, Letendre S, Lee SC., 2015. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals. J Neuroinflammation [Internet]. 12:72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25890304
37. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol [Internet]. 3:RESEARCH0034. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12184808
38. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D. 1999. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA [Internet]. 96:7324–7329. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10377413
39. Yao X, Sun S, Zhou X, Guo W, Zhang L., 2015. IGF-binding protein 2 is a candidate target of therapeutic potential in cancer. Tumour Biol [Internet]. 37:1451–1459. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26662106